A detailed history of Manchester Capital Management LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Manchester Capital Management LLC holds 92 shares of ILMN stock, worth $11,965. This represents 0.0% of its overall portfolio holdings.

Number of Shares
92
Previous 129 28.68%
Holding current value
$11,965
Previous $17,000 47.06%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$101.05 - $133.57 $3,738 - $4,942
-37 Reduced 28.68%
92 $9,000
Q1 2024

May 06, 2024

BUY
$127.73 - $147.2 $383 - $441
3 Added 2.38%
129 $17,000
Q4 2023

Feb 08, 2024

BUY
$92.79 - $142.53 $5,381 - $8,266
58 Added 85.29%
126 $17,000
Q3 2023

Nov 09, 2023

BUY
$128.91 - $192.44 $2,320 - $3,463
18 Added 36.0%
68 $9,000
Q3 2022

Nov 08, 2022

SELL
$177.23 - $227.44 $97,476 - $125,092
-550 Reduced 91.67%
50 $10,000
Q2 2022

Aug 10, 2022

SELL
$181.58 - $368.0 $86,068 - $174,432
-474 Reduced 44.13%
600 $111,000
Q4 2021

Feb 10, 2022

SELL
$347.28 - $421.83 $4,167 - $5,061
-12 Reduced 1.1%
1,074 $409,000
Q1 2021

May 13, 2021

BUY
$361.28 - $504.76 $214,600 - $299,827
594 Added 120.73%
1,086 $417,000
Q4 2020

Feb 16, 2021

BUY
$292.7 - $370.96 $878 - $1,112
3 Added 0.61%
492 $182,000
Q3 2020

Oct 27, 2020

BUY
$268.51 - $400.74 $805 - $1,202
3 Added 0.62%
489 $151,000
Q1 2020

May 14, 2020

BUY
$209.2 - $335.53 $99,160 - $159,041
474 Added 3950.0%
486 $133,000
Q3 2019

Nov 04, 2019

SELL
$266.84 - $378.23 $2,935 - $4,160
-11 Reduced 47.83%
12 $4,000
Q2 2018

Aug 08, 2018

SELL
$228.17 - $292.07 $1,369 - $1,752
-6 Reduced 20.69%
23 $6,000
Q1 2018

May 07, 2018

BUY
$209.54 - $253.91 $6,076 - $7,363
29 New
29 $7,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $20.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Manchester Capital Management LLC Portfolio

Follow Manchester Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.